Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
1
2
34
5
67
891011
12
1314
15
161718192021
22
23
2425262728
2930
31
    
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Opioid drug deaths up in Lowell

Catasys Health - Tuesday, July 31, 2012

By Jennifer Myers
Last year, 31 people died from opioid overdoses in Lowell, a figure that will likely rise once test results come back on 12 pending cases.

"If 31 people died from a pandemic flu or Eastern equine encephalitis, everyone would have their shorts in a knot," Lowell Health Department Director Frank Singleton said. "There would be a total panic. But no one talks about drug addiction or overdose."


"It has always been 'somebody else's problem,'" added state Rep. Tom Golden, who has championed bringing awareness and solutions to the problem for more than five years. "People have to realize this is all of our problem. It affects our families, our economy and, most importantly, the quality of life in our communities."
 » More


FDA opioid safety plan focuses on physician education

Catasys Health - Monday, July 23, 2012

By Christine S. Moyer
Educating health professionals on how to prescribe extended-release and long-acting opioids is among the federal government’s latest efforts to slow the rise in overdose deaths involving prescription painkillers.

Manufacturers of the powerful drugs will have to fund continuing education programs for physicians and others who prescribe the medications, according to a safety measure issued July 9 by the Food and Drug Administration. The training sessions will begin in March 2013, and participation will be voluntary for health professionals. At this article’s deadline, the FDA was looking into how the training will be offered.
 » More


Elton John: 'I wasted a big part of my life on cocaine'

Catasys Health - Sunday, July 15, 2012

By Beth Hilton
Sir Elton John has admitted that he "wasted a big part" of his life by using drugs.

The 65-year-old, who battled addictions to alcohol and cocaine until 1990, said that he wishes he had become clean sooner so he could fully enjoy his early career.


He told Matt Lauer on the Today show: "I wasted such a big part of my life. I was a drug addict and self-absorbed. You know, I was having people die right, left, and center around me, friends.


"And yet I didn't stop the life that I had, which is the terrible thing about addiction. It's that - you know, it's that bad of a disease."
 » More


With OxyContin farther from their grasp, more users switching to heroin

Catasys Health - Thursday, July 12, 2012

By Michelle Castillo
While efforts to curb OxyContin abuse seem to be succeeding, doctors are worried that addicts may be driven to use more dangerous opioids, including heroin.

Even though the formula of OxyContin has been changed to prevent the abuse of the drug through crushing or dissolving it in water for snorting or injection purposes, addiction to opioids still poses a problem.


"We're now seeing reports from across the country of large quantities of heroin appearing in rural and suburban areas," Dr. Theodore J. Cicero, vice chair of research at Washington University's department of psychiatry, told the Los Angeles Times. "Unable to use OxyContin easily, which was a very popular drug in rural and suburban areas, drug abusers who prefer snorting or IV drug administration now have shifted to more potent opioids if they can find them, or to heroin."
 » More


Methadone Deaths Outpace Mortality for Other Opioids

Catasys Health - Thursday, July 05, 2012

By: MARY ELLEN SCHNEIDER, Clinical Psychiatry News Digital Network
Methadone was involved in more than 30% of opioid-related deaths in the United States in 2009, second only to the painkiller oxycodone, according to new data from the Centers for Disease Control and Prevention.

The high rate of overdose deaths from methadone occurred even though the drug accounted for less than 2% of opioid prescriptions in 2009. Part of problem is that methadone is more likely than other opioids to cause an overdose, according to the CDC. For example, a toxic level of methadone can accumulate in the body, leading to severe respiratory depression. Methadone can also cause major disturbances in cardiac rhythm.


"It acts differently in different people’s bodies," Dr. Thomas R. Frieden, director of the CDC, said during a press conference to announce the new data. "So it’s possible that someone can take just a small amount, but it may last for days in their system and cause serious health problems."
 » More


Fighting prescription drug abuse, while treating pain, is a health care crisis

Catasys Health - Monday, July 02, 2012

By Sharon Meieran
The abuse, misuse and diversion of prescription drugs is a public health crisis. This is particularly apparent to those of us working in the emergency department, which is the largest ambulatory source of opioid medications. We all too frequently see individuals with untreated addiction issues, with life-threatening overdoses, and trying to obtain opioid medications for recreational use or to sell for profit.

The costs to individuals and society are devastating:


In 2009, for the first time, drug overdose exceeded motor vehicle collision as the leading cause of accidental death in Oregon.


Oregon is the fifth-highest state for nonmedical use of prescription painkillers, with nearly 700 associated poisoning deaths in 2003-2007.
 » More




| 1 |

 

 
  Tags
 
gabapentin Catasys SD members urine drug screen over-the-counter substances behavioral health substance dependence health insurance depression meth reduction in use addiction treatment morphine opiod abuse binge drinking relapse identification painkillers alcohol placebo methadone stratified care coaching cocaine treatment oxycodone addiction substance use disorder chronic pain facebook behavioral healthcare Co Occurring Disorders substance dependence medical smoking post-traumatic stress disorder pain pills drug abuse withdrawal nicotine cocaine mental health hospitalizations contract buprenorphine opiod-based addict Research Across America vivitrol dependence issues medical costs opioid-drug interactions drug addiction pain medication hospital percocet ADD opioid abuse SD health insurance medical and behavioral costs primary care codeine drinking sugar opioid opiates bipolar disorder diabetes alcohol drinking ADHD Opioid Medications marijuana methamphetamine drug use UnitedHealthcare opioid overdose physician- patient relations randomized psychosocial reduction in craving craving behavioral health care services sober predictive modeling anxiety high-utilizing drug overdose flumazenil OnTrak stress fentanyl emergency room Journal of Psychopharmacology relapse prevention recovery vicodin narcotic alcohol treatment suboxone Opioid Treatment prometa behavioral healthcare services data mining health plan CIWA trauma reducing craving depression screening drug addicts drug treatment craving score alcoholism OxyContin health reform PTSD overdose Health Care Utilization substance dependence costs pain killers Raymond Anton opioid antagonist recovery network muscle relaxant treatment health insurance ER prescriptions sobriety Harold Urschel heroin double-blind hydrocodone mental illness communication alcohol dependence cigarettes Opioid Prescribing methamphetamine dependence social network behavioral health care stimulants naloxone placebo-controlled
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414